GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (BOM:500288) » Definitions » Price-to-Operating-Cash-Flow

Morepen Laboratories (BOM:500288) Price-to-Operating-Cash-Flow : (As of Jun. 04, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Morepen Laboratories Price-to-Operating-Cash-Flow?

As of today (2025-06-04), Morepen Laboratories's share price is ₹64.53. Morepen Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00. Hence, Morepen Laboratories's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Morepen Laboratories's Price-to-Operating-Cash-Flow or its related term are showing as below:

BOM:500288' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 0   Max: 108.39
Current: 108.39

During the past 13 years, Morepen Laboratories's highest Price-to-Operating-Cash-Flow Ratio was 108.39. The lowest was 0.00. And the median was 0.00.

BOM:500288's Price-to-Operating-Cash-Flow is ranked worse than
92.29% of 687 companies
in the Drug Manufacturers industry
Industry Median: 17.78 vs BOM:500288: 108.39

Morepen Laboratories's Cash Flow from Operations per share for the three months ended in Mar. 2025 was ₹0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Morepen Laboratories was -58.30% per year.

During the past 13 years, Morepen Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.60% per year. The lowest was -76.80% per year. And the median was 7.80% per year.


Morepen Laboratories Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Morepen Laboratories's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories Price-to-Operating-Cash-Flow Chart

Morepen Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.53 - - 29.31 80.02

Morepen Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.31 - - - 80.02

Competitive Comparison of Morepen Laboratories's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morepen Laboratories's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's Price-to-Operating-Cash-Flow falls into.


;
;

Morepen Laboratories Price-to-Operating-Cash-Flow Calculation

Morepen Laboratories's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=64.53/0
=

Morepen Laboratories's Share Price of today is ₹64.53.
Morepen Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Morepen Laboratories Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Morepen Laboratories Business Description

Traded in Other Exchanges
Address
Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.

Morepen Laboratories Headlines

No Headlines